Belvedere
Research payments
$3,454,005
Through program year 2024, $3,454,005 in research payments was reported against Belvedere, across 393 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $1,007,353 | 117 |
| 2023 | Research | $1,451,991 | 180 |
| 2022 | Research | $861,684 | 75 |
| 2021 | Research | $132,976 | 21 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Arshad Khanani Dallas, TX Named on 89 payments
- Jordan Graff Iowa City, IA Named on 16 payments
- Charles Wykoff Houston, TX Named on 12 payments
- Peter Campochiaro Baltimore, MD Named on 12 payments
- Margaret Chang Baltimore, MD Named on 11 payments
- Allen Hu Los Angeles, CA Named on 9 payments
- Sara Haug San Francisco, CA Named on 9 payments
- Eric Suan Baltimore, MD Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.